Evusheld drug approved for use in people aged 12 and older who are immunocompromised or for whom COVID-19 vaccination is not recommended.
Health Canada has authorized a drug developed by AstraZeneca to prevent COVID-19 infections.
Evusheld has been cleared for people aged 12 and older who have a compromised immune system and are unlikely to get an adequate response to a COVID-19 vaccination, or for whom COVID-19 vaccination is not recommended.
The medication contains lab-made antibodies designed to remain in the body for months, which officials say will contain the virus if there is an infection.
The therapy has also been authorized in the United States and has been recommended by the European Medicines Agency.
Keep Talking Justice Reform: MP
NRP Warn of Opioid Overdose Surge
Teenagers Wanted After Welland Car Crash
Nurse Practitioner Impacting Niagara Falls ER
Grimsby, Port Colborne Honour Remembrance Day
St. Catharines Man Charged with Drug Dealing
Wainfleet Man Wins Lottery... 1st Time
MP Plans to Hear More Vaccine Injury Stories